ADCT vs MSFT · rev $40.1M vs P/E 39, rev $331.84B
ADC Therapeutics SA (ADCT) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
ADCT currently screens at market cap $141.2M. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the ADCT and MSFT stock pages for the full models.
Not investment advice.